Learning Objectives

  • Outline differences between neonatal seizures and seizures at other ages
  • Explain the relationship between neonatal seizures and adverse neurodevelopmental outcomes
    • Make a distinction between presence of neonatal seizures and seizure burden
  • Describe potential adverse effects of phenobarbital exposure in the neonatal period
  • Summarize data from previous studies supporting the efficacy of phenobarbital and levetiracetam
  • Compare data from previous studies to outcomes of patients treated for neonatal seizures at UW

 

Evaluation

Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135

Session date: 
Monday, May 17, 2021 - 4:00pm to 5:00pm
Location: 
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Andrew Knox, MD